Understanding how a specific gene affects brain cell development in Alzheimer's disease
Investigation into transcriptomic control of dentate granule cell maturation and hyperexcitability in the apoE4 Alzheimer's Disease model
This study is looking at how a specific gene called apoE4 affects brain cells that help with memory, especially in people with Alzheimer's disease, to better understand early changes in the brain that might lead to memory problems.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | J. David Gladstone Institutes NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project ID | NIH-10995282 on NIH RePORTER |
What this research studies
This research investigates the role of the apoE4 gene in the maturation and hyperactivity of brain cells involved in memory, specifically in the context of Alzheimer's disease. By studying both human and mouse models, the researchers aim to understand how apoE4 influences the development of dentate granule cells, which are crucial for memory function. The approach includes advanced techniques like single-nucleus RNA sequencing to analyze gene expression in these cells. The findings could provide insights into early changes in the brain that lead to cognitive decline in Alzheimer's patients.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who carry the apoE4 gene and are at risk for developing Alzheimer's disease.
Not a fit: Patients without the apoE4 gene or those who are already diagnosed with advanced Alzheimer's disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new strategies for preventing or treating cognitive decline in individuals at risk for Alzheimer's disease.
How similar studies have performed: Previous research has shown promising results in understanding the role of genetic factors in Alzheimer's disease, suggesting that this approach could yield valuable insights.
Where this research is happening
San Francisco, United States
- J. David Gladstone Institutes — San Francisco, United States (Active)
Researchers
- Principal investigator: Tabuena, Dennis R — J. David Gladstone Institutes
- Study coordinator: Tabuena, Dennis R
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.